At the news
? NEUTRALIMPACT 4/10 6-K filed May 7, 2026 at 08:20 ET
BioNTech announced a new $1.0 billion ADS repurchase program authorized through May 6, 2027, to be funded from existing cash. The program is designed to enhance capital efficiency and support long-term value creation, but it does not offset the company's declining revenue trend.
- Up to $1.0 billion in ADS repurchases authorized.
- Program expires May 6, 2027.
- Repurchases will be funded from existing cash.
- ADSs repurchased will be used to satisfy ordinary course obligations.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access